V-IMMUNE® for Immune Thrombocytopenia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

V-IMMUNE® for Immune Thrombocytopenia — Stella

Recruiting

Back to Immune Thrombocytopenia (ITP) trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

Brazil

IMIP Instituto de Medicina Integral Professor Fernando Figueira, Recife, Pernambuco

Santa Casa de Misericórida de São Paulo, São Paulo, São Paulo

Key details

Phase

Large-scale testing

Sponsor

On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.

Collaborators

Hospital do Coracao

Enrollment target

~31 participants

Started

July 2025

Primary completion

August 2026

Age range

1 Year and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov